My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Pfizer moves higher after undertaking review of its respiratory portfolio
Nov 29,2016

The announcement was made after market hours yesterday, 28 November 2016.

Meanwhile, the S&P BSE Sensex was up 200.17 points or 0.76% at 26,550.34.

On the BSE, 1,152 shares were traded on the counter so far as against the average daily volumes of 2,553 shares in the past one quarter. The stock had hit a high of Rs 1,850 and a low of Rs 1,818 so far during the day. The stock had hit a 52-week high of Rs 2,540 on 7 December 2015. The stock had hit a 52-week low of Rs 1,611 on 21 March 2016. The stock had outperformed the market over the past one month till 28 November 2016, sliding 0.64% compared with the Sensexs 5.7% fall. The scrip had, however, underperformed the market in past one quarter, declining 7.04% as against the Sensexs 5.15% fall.

The mid-cap company has equity capital of Rs 45.75 crore. Face value per share is Rs 10.

Pfizer has undertaken a comprehensive review of its respiratory offerings to better cover a broader range of indications through an expanded product portfolio. As a result of this review, the company will launch additional products while it may also discontinue the manufacture of certain SKUs where needed.

Pfizer will be launching a series of products as line extensions under the Corex brand name, starting with the first launch in December 2016 and subsequent launches over the next year.

The company has also decided to discontinue the manufacturing of the current Corex Cough Syrup formulation (Codeine Phosphate 10mg + Chlorpheniramine Maleate 4mg).

Pfizer said it stands by the safety and efficacy of its current Corex Cough Syrup formulation that has been duly approved by Central and state regulators. As with this formulation, all additional line extensions will be introduced with all due regulatory approvals in place, it added.

Corex Cough Syrup recorded a sale of Rs 244.48 crore for the financial year ended 31 March 2016.

Pfizers net profit rose 52.5% to Rs 126.33 crore on 4.9% growth in net sales to Rs 530.02 crore in Q2 September 2016 over Q2 September 2015.

Pfizer is a leading biopharmaceutical company.

Powered by Capital Market - Live News

Natco Pharma gains after USFDA approval for generic drug
Nov 29,2016

The announcement was made during trading hours today, 29 November 2016.

Meanwhile, the BSE Sensex was up 174.93 points, or 0.66%, to 26,525.10.

On BSE, so far 25,000 shares were traded in the counter, compared with average daily volume of 30,786 shares in the past one quarter. The stock hit a high of Rs 626 and a low of Rs 612.40 so far during the day. The stock hit a record high of Rs 703.95 on 25 August 2016. The stock hit a 52-week low of Rs 390 on 29 March 2016. The stock had outperformed the market over the past 30 days till 28 November 2016, rising 2.36% compared with the 5.66% decline in the Sensex. The scrip had, however, underperformed the market in past one quarter, falling 10.65% as against Sensexs 7.03% decline.

The large-cap company has equity capital of Rs 34.86 crore. Face value per share is Rs 2.

Natco Pharma announced receiving final approval of Abbreviated New Drug Application (ANDA) containing a paragraph IV certification filed with the US Food and Drug Administration (USFDA) for generic version of Armodafinil tablets, 50 milligrams (mg), 150 mg, and 250 mg. Natco and its marketing partner Breckenridge Pharmaceutical, Inc., plan to launch this product in the US market immediately.

Cephalon (acquired by Teva in 2011) sells Armodafinil 50mg, 150mg, and 250mg tablets under brand name NUVUGIL in the US market. NUVUGIL is a wakefulness promoting agent for oral administration. NUVUGIL Tablets had US sales of approximately $480 million for twelve months ending December 2015, according to IMS Health.

On a consolidated basis, net profit of Natco Pharma rose 127.21% to Rs 66.55 crore on 75.56% rise in net sales to Rs 415.21 crore in Q2 September 2016 over Q2 September 2015.

Natco Pharma manufactures generic dosage forms, bulk actives and intermediates for the Indian and international markets.

Powered by Capital Market - Live News

Himachal Futuristic Communications standalone net profit declines 60.51% in the September 2016 quarter
Nov 29,2016

Net profit of Himachal Futuristic Communications declined 60.51% to Rs 24.89 crore in the quarter ended September 2016 as against Rs 63.03 crore during the previous quarter ended September 2015. Sales declined 29.62% to Rs 413.47 crore in the quarter ended September 2016 as against Rs 587.52 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales413.47587.52 -30 OPM %9.7912.68 - PBDT28.1469.21 -59 PBT24.8962.76 -60 NP24.8963.03 -61

Powered by Capital Market - Live News

Cox & Kings consolidated net profit declines 76.63% in the September 2016 quarter
Nov 29,2016

Net profit of Cox & Kings declined 76.63% to Rs 27.32 crore in the quarter ended September 2016 as against Rs 116.91 crore during the previous quarter ended September 2015. Sales rose 11.70% to Rs 2557.84 crore in the quarter ended September 2016 as against Rs 2289.91 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales2557.842289.91 12 OPM %7.3513.83 - PBDT137.80270.59 -49 PBT115.51243.03 -52 NP27.32116.91 -77

Powered by Capital Market - Live News

Jayaswal Neco Industries reports standalone net loss of Rs 99.04 crore in the September 2016 quarter
Nov 29,2016

Net Loss of Jayaswal Neco Industries reported to Rs 99.04 crore in the quarter ended September 2016 as against net loss of Rs 3.34 crore during the previous quarter ended September 2015. Sales declined 12.20% to Rs 630.50 crore in the quarter ended September 2016 as against Rs 718.09 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales630.50718.09 -12 OPM %14.719.25 - PBDT-36.0723.43 PL PBT-101.084.88 PL NP-99.04-3.34 -2865

Powered by Capital Market - Live News

Cox & Kings standalone net profit declines 16.31% in the September 2016 quarter
Nov 29,2016

Net profit of Cox & Kings declined 16.31% to Rs 34.32 crore in the quarter ended September 2016 as against Rs 41.01 crore during the previous quarter ended September 2015. Sales rose 8.72% to Rs 714.82 crore in the quarter ended September 2016 as against Rs 657.50 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales714.82657.50 9 OPM %7.689.46 - PBDT62.8765.99 -5 PBT56.8558.63 -3 NP34.3241.01 -16

Powered by Capital Market - Live News

Hindustan Composites standalone net profit declines 31.96% in the September 2016 quarter
Nov 29,2016

Net profit of Hindustan Composites declined 31.96% to Rs 10.88 crore in the quarter ended September 2016 as against Rs 15.99 crore during the previous quarter ended September 2015. Sales declined 9.94% to Rs 44.31 crore in the quarter ended September 2016 as against Rs 49.20 crore during the previous quarter ended September 2015.

ParticularsQuarter Endedn++Sep. 2016Sep. 2015% Var. Sales44.3149.20 -10 OPM %37.9847.38 - PBDT16.8823.38 -28 PBT14.9721.78 -31 NP10.8815.99 -32

Powered by Capital Market - Live News

Tata Communications launches IZOn++ SDWAN
Nov 29,2016

Tata Communications has launched the latest addition to its IZOn++ cloud enablement platform - IZOn++ SDWAN. As the myriad of different applications, clouds, data sources and connections create complexity for organisations, IZOn++ SDWAN helps them detangle this complexity and propel their growth through seamless, secure and easy-to manageconnectivity across 130 countries spanning both developed and emerging markets.

Underpinned by Tata Communications global network, IZOn++ ecosystem, and partnerships with the worlds biggest cloud companies, IZOn++ SDWAN boosts agility and flexibility for organisations. By enabling the instant deployment of branch office networks anywhere in the world, the new service helps organisations to expand and introduce new products and services faster, and adapt to rapidly changing market conditions.

Tata Communications fast-growing IZOn++ ecosystem gives multinational organisations the freedom to choose a cloud environment best suited to their requirements, underpinned by Tata Communications leading global network and partnerships.

Powered by Capital Market - Live News

Cox & Kings slips on weak Q2 results
Nov 29,2016

The result was announced after market hours yesterday, 28 November 2016.

Meanwhile, the BSE Sensex was up 190.99 points, or 0.72%, to 26,541.16.

On BSE, so far 80,000 shares were traded in the counter, compared with average daily volume of 1.71 lakh shares in the past one quarter. The stock hit a high of Rs 166.30 and a low of Rs 159.10 so far during the day. The stock hit a 52-week high of Rs 256.45 on 6 January 2016. The stock hit a 52-week low of Rs 140.50 on 17 February 2016. The stock had underperformed the market over the past 30 days till 28 November 2016, falling 26.52% compared with the 5.66% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 12.70% as against Sensexs 7.03% decline.

The small-cap company has equity capital of Rs 88.28 crore. Face value per share is Rs 5.

Cox & Kings is a leading leisure and education travel group with operations in 22 countries across 4 continents.

Powered by Capital Market - Live News

Bharat Financial Inclusion jumps on foreign brokerage rating
Nov 29,2016

Meanwhile, the S&P BSE Sensex was up 177.12 points or 0.67% at 26,527.29.

On BSE, so far 3.08 lakh shares were traded in the counter as against average daily volume of 2.11 lakh shares in the past one quarter. The stock hit a high of Rs 734.50 and a low of Rs 691 so far during the day. The stock had hit a 52-week high of Rs 938.75 on 29 July 2016. The stock had hit a 52-week low of Rs 434.85 on 9 December 2015. The stock had underperformed the market over the past one month till 28 November 2016, sliding 22.94% compared with the Sensexs 5.7% fall. The scrip had also underperformed the market in past one quarter, declining 13.28% as against the Sensexs 5.15% fall.

The mid-cap company has equity capital of Rs 137.91 crore. Face value per share is Rs 10.

The foreign brokerage reportedly said that Bharat Financial Inclusion has collected 89% of its overall dues over the period from 11 November to 25 November 2016.

Bharat Financial Inclusions net profit rose 87.4% to Rs 145.88 crore on 38.6% increase in total income to Rs 449.60 crore in Q2 September 2016 over Q2 September 2015.

Bharat Financial Inclusion is among the largest microfinance companies in India.

Powered by Capital Market - Live News

Surana Solar spurts after winning order
Nov 29,2016

The announcement was made after market hours yesterday, 28 November 2016.

Meanwhile, the BSE Sensex was up 166.80 points, or 0.63%, to 26,516.97.

On BSE, so far 1.04 lakh shares were traded in the counter, compared with average daily volume of 25,420 shares in the past one quarter. The stock hit a high of Rs 25.10 and a low of Rs 23.80 so far during the day. The stock hit a 52-week high of Rs 39.75 on 7 January 2016. The stock hit a 52-week low of Rs 19 on 24 June 2016. The stock had underperformed the market over the past 30 days till 28 November 2016, falling 9.71% compared with the 5.66% decline in the Sensex. The scrip had also underperformed the market in past one quarter, falling 8.96% as against Sensexs 7.03% decline.

The small-cap company has equity capital of Rs 24.60 crore. Face value per share is Rs 5.

Surana Solar has been awarded an engineering procurement construction (EPC) contract for design, engineering, procurement & supply, construction & erection, testing, commissioning, associated transmission system & comprehensive operation & maintenance for 10 years of a 10 megawatts (MW) (AC) solar power plant by Paradip Port Trust, Odisha (India). The total EPC contract awarded is Rs 60.60 crore and for Operations and Maintenance (O&M) works for ten years is Rs 4.75 crore, which is more than 50% of the turnover of the financial year 2015-2016.

Net profit of Surana Solar rose 7.50% to Rs 0.43 crore on 25.30% decline in net sales to Rs 17.69 crore in Q2 September 2016 over Q2 September 2015.

Surana Solar is one of the leading manufacturers of solar photovoltaic modules in India.

Powered by Capital Market - Live News

Cipla appoints director
Nov 29,2016

Cipla has appointed Ireena Vittal as an independent director on its Board with effect from 01 December 2016.

Powered by Capital Market - Live News

GTL announces change in nominee director
Nov 29,2016

GTL announced that, as a part of routine lenders nomination process, IDBI Bank has nominated adri Srinivasa Rao - Chief General Manager, as a Director on the Companys Board in place of its earlier Nominee, Dilip Kumar Mandal - Chief General Manager. The said change is effective 28 November 2016.

Powered by Capital Market - Live News

2.5 Crore Free Electricity Connections Provided to BPL Households
Nov 29,2016

Under DeenDayalUpadhyaya Gram Jyoti Yojana (DDUGJY), Government of India is providing free electricity connections to BPL households. Out of total 4.27 crore connections sanctioned, free electricity connections to 2.5 crore BPL households have been provided as on 31.10.2016 under the scheme.

State-wise Coverage and Achievement of BPL Households under DDUGJY (including RE component)

Sl. No.Name of the StateCoverageAchievement                                     
(As on 31.10.2016)
1Andhra Pradesh245728724145552Arunachal Pradesh74679516213Assam179460412102244Bihar1066085237670195Chhattisgarh144899711433436Gujarat8480058429457Haryana2579021985808Himachal Pradesh19578162909Jammu & Kashmir1428856914810Jharkhand2367897127517011Karnataka103696695009812Kerala19291915030513Madhya Pradesh3209701166840714Maharashtra1621836122135015Manipur1375257030716Meghalaya12175810438317Mizoram306432971018Nagaland986165455919Odisha4499998277672320Punjab929889298821Rajasthan1791657116642622Sikkim136011360123Tamil Nadu52646850209424Telangana112530670886525Tripura20873213796226Uttar Pradesh5212392191094827Uttarakhand23840423792128West Bengal24800342204398Grand Total4271244624989940

In order to provide access to electricity to all rural households and also ensure quality and reliability of power supply in rural areas, Government of India has launched DeenDayalUpadhyaya Gram Jyoti Yojana (DDUGJY) with an outlay of Rs.43033 crore and Budgetary support of Rs.33453 crore consisting of separation of agriculture and non-agriculture feeders, strengthening and augmentation of sub-transmission and distribution network, metering at all level and rural electrification.  In addition to this, rural electrification component projects with total outlay of Rs.32860 crore including budgetary support from Government of India of Rs.29574 crore have been subsumed in DDUGJY.  Under the scheme, adequate infrastructure would be created in all the villages to provide access to electricity to all households.  Release of service connections to households is the responsibility of concerned State DISCOM / Power Department. Projects under the scheme are to be completed in 24 months from the date of award.

Powered by Capital Market - Live News

Vardhman Textiles fixes record date for buyback of shares
Nov 29,2016

Vardhman Textiles has fixed 09 December 2016 as the Record Date for the purpose of Buyback of Equity Shares.

Powered by Capital Market - Live News